Search results
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
Reuters via Yahoo Finance· 6 days agoHYDERABAD/BENGALURU (Reuters) -Cipla is open to partnering with U.S. drugmaker Eli Lilly to market its blockbuster obesity treatment drugs in India, the company's CEO said ...
Blockbuster Drug Patent Thickets Signal 'Strategic Behavior'
MedPage Today· 3 days agoThe share of patents filed post-approval was higher for the four biologics than for the six small...
Toyota's Blockbuster Report Amid The EV Slowdown Reflect Its Determination To Catch Up On Software
Benzinga via Yahoo Finance· 7 days agoOn Wednesday, Toyota Motor Company (NYSE: TM) reported a blockbuster fourth quarter to end its...
China Film Pavilion Returns to Cannes With Sights Set on Future Partnerships
The Hollywood Reporter via Yahoo News· 2 hours agoChina officially arrives back at Cannes this year intent on showcasing its hits, while promoting the...
Xbox Debating Call of Duty Game Pass Launch Due to Revenue Loss – Report
Playstation Lifestyle via Yahoo News· 7 days agoSony has previously expressed concerns that Microsoft launching the annual blockbuster day-one on...
Nvidia Surges After Google AI Conference; Is The Stock A Buy Now?
Investor's Business Daily· 15 hours agoIt reported three quarters of declining year-over-year sales and four quarters of tapering earnings....
Stocks Book Weekly Gains, Extend May Rise
The Wall Street Journal· 6 days agoThe Nasdaq fell even more slightly. The Dow extended its longest winning streak of the year. The world’s biggest contract chip manufacturer, Taiwan’s...
Is This a Setback for Moderna?
Motley Fool via Yahoo Finance· 2 days agoOnce the source of more than $18 billion in annual revenue, the vaccine is now bringing in considerably less -- $6.7 billion last year -- as fewer people...
Earnings call: Zai Lab outlines robust growth, pipeline prospects By Investing.com
Investing.com· 6 days agoZai Lab Limited (NASDAQ:ZLAB) reported significant growth in its first-quarter 2024 financial...
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy
Motley Fool via Yahoo Finance· 4 days agoThe Motley Fool has positions in and recommends CRISPR Therapeutics and Vertex Pharmaceuticals. The...